Terms: = Prostate cancer AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL
4920 results:
1. Predicting clinically significant prostate cancer following suspicious mpMRI: analyses from a high-volume center.
Jahnen M; Hausler T; Meissner VH; Ankerst DP; Kattan MW; Sauter A; Gschwend JE; Herkommer K
World J Urol; 2024 May; 42(1):290. PubMed ID: 38702557
[TBL] [Abstract] [Full Text] [Related]
2. Plant-Based Diets and Disease Progression in Men With prostate cancer.
Liu VN; Van Blarigan EL; Zhang L; Graff RE; Loeb S; Langlais CS; Cowan JE; Carroll PR; Chan JM; Kenfield SA
JAMA Netw Open; 2024 May; 7(5):e249053. PubMed ID: 38691361
[TBL] [Abstract] [Full Text] [Related]
3. CDK9 inhibition activates innate immune response through viral mimicry.
Yalala S; Gondane A; Poulose N; Liang J; Mills IG; Itkonen HM
FASEB J; 2024 Apr; 38(8):e23628. PubMed ID: 38661032
[TBL] [Abstract] [Full Text] [Related]
4. Acoustic Enrichment of Heterogeneous Circulating Tumor Cells and Clusters from Metastatic prostate cancer Patients.
Magnusson C; Augustsson P; Undvall Anand E; Lenshof A; Josefsson A; Welén K; Bjartell A; Ceder Y; Lilja H; Laurell T
Anal Chem; 2024 May; 96(18):6914-6921. PubMed ID: 38655666
[TBL] [Abstract] [Full Text] [Related]
5. Discovery and Mechanistic Studies of Dual-Target Hits for Carbonic Anhydrase IX and VEGFR-2 as Potential Agents for Solid Tumors: X-ray,
Hefny SM; El-Moselhy TF; El-Din N; Giovannuzzi S; Bin Traiki T; Vaali-Mohammed MA; El-Dessouki AM; Yamaguchi K; Sugiura M; Shaldam MA; Supuran CT; Abdulla MH; Eldehna WM; Tawfik HO
J Med Chem; 2024 May; 67(9):7406-7430. PubMed ID: 38642371
[TBL] [Abstract] [Full Text] [Related]
6. [Application of 1470 nm semiconductor laser in the treatment of benign prostatic hyperplasia in ultra-aged patients].
Wu D; Yi XM; Wei HX; Zhang KX; Shi CJ; Shi XQ; Xu ZY; Fu D
Zhonghua Nan Ke Xue; 2023 Sep; 29(9):831-836. PubMed ID: 38639597
[TBL] [Abstract] [Full Text] [Related]
7. Discovery of the First-in-Class G9a/GLP PROTAC Degrader.
Velez J; Han Y; Yim H; Yang P; Deng Z; Park KS; Kabir M; Kaniskan HÜ; Xiong Y; Jin J
J Med Chem; 2024 Apr; 67(8):6397-6409. PubMed ID: 38602846
[TBL] [Abstract] [Full Text] [Related]
8. ISIT-QA: In Silico Imaging Trial to Evaluate a Low-Count Quantitative SPECT Method Across Multiple Scanner-Collimator Configurations for
Li Z; Benabdallah N; Luo J; Wahl RL; Thorek DLJ; Jha AK
J Nucl Med; 2024 May; 65(5):810-817. PubMed ID: 38575187
[TBL] [Abstract] [Full Text] [Related]
9. A phase I study of docetaxel plus synthetic lycopene in metastatic prostate cancer patients.
Lilly MB; Wu C; Ke Y; Chen WP; Soloff AC; Armeson K; Yokoyama NN; Li X; Song L; Yuan Y; McLaren CE; Zi X
Clin Transl Med; 2024 Mar; 14(3):e1627. PubMed ID: 38515274
[TBL] [Abstract] [Full Text] [Related]
10. Neighborhood Deprivation, Race and Ethnicity, and prostate cancer Outcomes Across California Health Care Systems.
Wadhwa A; Roscoe C; Duran EA; Kwan L; Haroldsen CL; Shelton JB; Cullen J; Knudsen BS; Rettig MB; Pyarajan S; Nickols NG; Maxwell KN; Yamoah K; Rose BS; Rebbeck TR; Iyer HS; Garraway IP
JAMA Netw Open; 2024 Mar; 7(3):e242852. PubMed ID: 38502125
[TBL] [Abstract] [Full Text] [Related]
11. Multivitamin use after diagnosis and prostate cancer survival among men with nonmetastatic prostate cancer.
Zhang Y; Stopsack KH; Wu K; Song M; Mucci LA; Giovannucci E
Br J Cancer; 2024 Jun; 130(10):1709-1715. PubMed ID: 38491175
[TBL] [Abstract] [Full Text] [Related]
12. Compliance With NCCN Guidelines for Evaluation and Treatment of Anemia Among Patients With Solid Tumors.
Hufnagel DH; Bos LM; Brown AJ; Prescott LS
J Natl Compr Canc Netw; 2024 Mar; 22(3):. PubMed ID: 38489926
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic Performance of RECIP 1.0 Based on [
Hartrampf PE; Hüttmann T; Seitz AK; Kübler H; Serfling SE; Higuchi T; Schlötelburg W; Michalski K; Gafita A; Rowe SP; Pomper MG; Buck AK; Werner RA
J Nucl Med; 2024 Apr; 65(4):560-565. PubMed ID: 38453363
[TBL] [Abstract] [Full Text] [Related]
14. Combination of navitoclax (Bcl-2 and Bcl-xL inhibitor) and Debio-0932 (Hsp90 inhibitor) suppresses the viability of prostate cancer cells via induction of apoptotic signaling pathway.
Asdemir A; Özgür A
Med Oncol; 2024 Mar; 41(4):83. PubMed ID: 38436810
[TBL] [Abstract] [Full Text] [Related]
15. A phase 2 pilot study of water irrigation after transurethral resection of bladder tumor (WATIP) demonstrating safety, feasibility and activity.
Li M; Nandurkar R; Toniolo J; Davis ID; Sengupta S
World J Urol; 2024 Mar; 42(1):115. PubMed ID: 38436768
[TBL] [Abstract] [Full Text] [Related]
16. A phase 2 study of AZD4635 in combination with durvalumab or oleclumab in patients with metastatic castration-resistant prostate cancer.
Falchook GS; Reeves J; Gandhi S; Spigel DR; Arrowsmith E; George DJ; Karlix J; Pouliot G; Hattersley MM; Gangl ET; James GD; Thompson J; Russell DL; Patel B; Kumar R; Lim E
Cancer Immunol Immunother; 2024 Mar; 73(4):72. PubMed ID: 38430405
[TBL] [Abstract] [Full Text] [Related]
17. Combining magnetic resonance imaging with a multi-ancestry polygenic risk score to improve identification of clinically significant prostate cancer.
Plym A; Madueke I; Naik S; Isabelle M; Conti DV; Haiman CA; Penney KL; Mucci LA; Khorasani R; Kibel AS
JNCI Cancer Spectr; 2024 Feb; 8(2):. PubMed ID: 38429995
[TBL] [Abstract] [Full Text] [Related]
18. Healthy dietary patterns and risk of prostate cancer in men at high genetic risk.
Zhang Y; Stopsack KH; Song M; Mucci LA; Liu B; Penney KL; Tabung FK; Giovannucci E; Plym A
Int J Cancer; 2024 Jul; 155(1):71-80. PubMed ID: 38429859
[TBL] [Abstract] [Full Text] [Related]
19. Single-Time-Point Renal Dosimetry Using Nonlinear Mixed-Effects Modeling and Population-Based Model Selection in [
Hardiansyah D; Yousefzadeh-Nowshahr E; Kind F; Beer AJ; Ruf J; Glatting G; Mix M
J Nucl Med; 2024 Apr; 65(4):566-572. PubMed ID: 38423787
[TBL] [Abstract] [Full Text] [Related]
20. Development and Preclinical Evaluation of [
El Fakiri M; Ayada N; Müller M; Hvass L; Gamzov TH; Clausen AS; Geis NM; Steinacker N; Hansson E; Lindegren S; Aneheim E; Jensen H; Eder AC; Jensen AI; Poulie CBM; Kjaer A; Eder M; Herth MM
J Nucl Med; 2024 Apr; 65(4):593-599. PubMed ID: 38423784
[TBL] [Abstract] [Full Text] [Related]
[Next]
